factual

Asacol Delzicol Useless Capsule Blocked Generics

In the Asacol/Delzicol case the company introduced a new patented product identical to the old drug except for an ineffective capsule that did nothing, then withdrew the original Asacol from the market; because pharmacists could not substitute a generic of the now-unavailable original, and generics could not add a matching capsule without infringing the new patent, the maneuver blocked generic competition despite the change being therapeutically meaningless.

factualpending

Speaker

Robin Feldman

Evidence Quote

“it introduced a new product, which was the same drug except with an ineffective capsule around it... Even the FDA agreed that the two drugs were exactly the same.”

Source

Robin Feldman on Drug Patents, Generics, and Drug Wars— EconTalk
Created: 6/13/2026, 12:11:23 AM

Your notes

Loading notes...